Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 4c
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.80), $0.04 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.
Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.80), $0.04 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.